Accelerated, Dose escalated, Sequential Chemoradiotherapy in Non-small-cell lung cancer (ADSCaN): A protocol for a randomised phase II study

Matthew Q.F. Hatton*, Claire Anne Lawless, Corinne Faivre-Finn, David Landau, Jason F. Lester, John Fenwick, Rita Simões, Elaine McCartney, Kathleen Anne Boyd, Tom Haswell, Ann Shaw, James Paul

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Accelerated, Dose escalated, Sequential Chemoradiotherapy in Non-small-cell lung cancer (ADSCaN): A protocol for a randomised phase II study'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science